Investigation of bacterial inactivation in apheresis platelets with 24 or 30 hours between inoculation and inactivation

Vox Sanguinis

Volumn 111, Issue 3, 2016, Pages 226-234

  Wagner, S J ^a   Benjamin, R J ^b   Hapip, C A ^a   Kaelber, N S ^a   Turgeon, A M ^a   Skripchenko, A ^a   Stassinopoulos, A ^b  

^a HOLLAND LABORATORY   (United States)

^b CERUS CORPORATION   (United States)

Author keywords

bacteria; inactivation; platelet

Indexed keywords

APHERESIS; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM EXAMINATION; BLOOD CULTURE; COLONY FORMING UNIT; ESCHERICHIA COLI; INOCULATION; KLEBSIELLA PNEUMONIAE; NONHUMAN; PATHOGEN INACTIVATION; PLATE COUNT; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES; BACTERIUM; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; RADIATION RESPONSE; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; ULTRAVIOLET RADIATION;

AMOTOSALEN; FUROCOUMARIN DERIVATIVE; PHOTOSENSITIZING AGENT;

BACTERIA; BLOOD PLATELETS; FUROCOUMARINS; HUMANS; KLEBSIELLA PNEUMONIAE; PHOTOSENSITIZING AGENTS; PLATELET COUNT; PLATELET TRANSFUSION; PLATELETPHERESIS; ULTRAVIOLET RAYS;

EID: 84969972175     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12410     Document Type: Article

References (28)

1. Eder AF, Dy BA, Notari EP, et al.: Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009; 49:1554–1563
2. Benjamin RJ, Dy B, Perez J, et al.: Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results. Vox Sang 2014; 106:23–30
3. Hong H, Xiao W, Lazarus HM, et al.: Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood 2016; 127:496–502
4. Prowse CV: Component pathogen inactivation: a critical review. Vox Sang 2013; 104:183–199
5. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM427512.pdf[last accessed 04 Apr 2016]
6. CE Mark. Instruction for Use for INTERCEPT Small Volume Kit, 28-59-01-105A ver. 2016-01-11
7. Nussbaumer W, Allerstorfer D, Grabmer C, et al.: Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods. Transfusion 2007; 47:1125–1133
8. Schmidt M, Hfar MK, Sireis W, et al.: Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion-transmitted bacterial strains. Transfusion 2015; 55:2104–2112
9. Goodrich RP, Gilmour D, Hovenga N, et al.: A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion 2009; 49:1205–1216
10. Kwon SY, Kim IS, Bae JE, et al.: Pathogen inactivation efficacy of Mirasol PRT system and Intercept Blood System for non-leukoreduced platelet –rich plasma-derived platelets suspended in plasma. Vox Sang 2014; 107:254–260
11. Benjamin RJ, Wagner SJ: Bacterial pathogen reduction requires validation under conditions of intended use. Transfusion 2015; 55:2060–2063
12. Störmer M, Arroyo A, Brachert J, et al.: Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria. Vox Sang 2012; 102:22–31
13. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM427512.pdf accessed 9102015 [Last accessed 04 Apr 2016]
14. Dumont LJ, Kleinman S, Murphy JR, et al.: Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010; 50:589–599
15. Murphy WG, Foley M, Doherty C, et al.: Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008; 95:13–19
16. Pearce S, Rowe GP, Field SP: Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011; 21:25–32
17. Kleinman S, Reed W, Stassinopoulos A: A patient-oriented risk–benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States. Transfusion 2013; 53:1603–1618
18. Benjamin RJ, Wagner SJ: The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007; 47:1381–1389
19. Jacobs MR, Smith D, Heaton WA, et al.: Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Tranfusion 2011; 51:2573–2582
20. Heaton WA, Good CE, Galloway-Haskins R, et al.: Evaluation of a rapid colorimetric assay for detection of bacterial contamination in apheresis and pooled random-donor platelet units. Transfusion 2014; 54:1634–1641
21. Corash L: Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis. Expert Rev Hematol 2011; 4:509–525
22. Lin L, Dikeman R, Molini B, et al.: Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004; 44:1496–1504
23. Goodrich RP, Edrich RA, Li J, et al.: The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006; 35:5–17
24. Ruane PH, Edrich R, Gampp D, et al.: Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44:877–885
25. Keil SD, Hovenga N, Gilmour D, et al.: Treatment of platelet products with riboflavin and uv light: effectiveness against high titer bacterial contamination. J Vis Exp 2015 Aug 24; 102:e52820
26. Mohr H, Gravemann U, Muller TH: Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light. Transfusion 2009; 49:2144–2151
27. Mohr H, Gravemann U, Bayer A, et al.: Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light. Transfusion 2009; 49:1956–1963
28. Walther-Wenke G, Schrezenmeier H, Deitenbeck R, et al.: Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up. Ann Hematol 2010 Jan; 89:83–91